
Kixta 100mg Capsule
Marketer
Zydus Healthcare Limited
Salt Composition
Palbociclib (100mg)
Overview Kixta 100mg Capsule
Estramustine 100mg capsules are indicated for managing certain metastatic breast cancers (estrogen receptor-positive, HER2-negative). This medication is administered concurrently with hormonal anti-cancer treatments. For optimal absorption, ingest Estramustine 100mg capsules with food, aiming for consistent daily timing. Dosage and frequency are determined by your physician, based on your individual needs and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosing can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under your doctor's guidance. Common side effects encompass tiredness, alopecia, skin rashes, nausea, and bowel irregularities. This medication can lower blood cell counts (red and white), potentially increasing infection risk. Report any infection signs (fever, chills, weakness, bleeding, bruising, epistaxis) to your doctor immediately. Dizziness may occur; avoid driving or tasks requiring alertness if affected. Prior to commencing treatment, inform your doctor about any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is crucial throughout treatment.
Primary Ingredients of Kixta 100mg Capsule
No text provided. Please provide the text you would like me to rephrase.
Uses of Kixta 100mg Capsule
Malignancy of the mammary gland
Major Benefits of Kixta 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Kixta 100mg Capsules with food.
Common Side effects of Kixta 100mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Kixta 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Kixta 100mg Capsules with food.
How Kixta 100mg Capsule works:
Kixta 100mg capsules are an anti-neoplastic agent. Their mechanism involves blocking cyclin-dependent kinases 4 and 6, key proteins in cellular signaling pathways that drive cell growth. This inhibition halts the cancerous cell cycle, preventing further proliferation. The drug's action is particularly effective against estrogen receptor-positive breast cancers by interfering with their cellular replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Kixta 100mg Capsule with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Kixta 100mg Capsules during pregnancy poses a confirmed risk to the fetus. While a physician might exceptionally prescribe it in life-threatening circumstances where benefits outweigh potential harm, it's crucial to seek medical advice before use.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Kixta 100mg capsules. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Kixta 100mg Capsules, as they can induce fatigue in some individuals. Therefore, caution is advised when operating machinery or vehicles if experiencing this side effect.
KidneySAFE IF PRESCRIBED
Kixta 100mg capsules may be administered to patients with renal impairment without requiring a change in dosage.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Kixta 100mg capsules. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Kixta 100mg Capsule :
NA
Facts to Know About Kixta 100mg Capsule
Label | Value |
---|---|
Chemical Category | Piperazine-pyridines |
Developing Habits | No. |
Type of Therapy | Cancer Medications |
Behavior Class | CDK Inhibitor |